Skip to main content
Top
Published in: Journal of Cancer Survivorship 3/2022

11-06-2021 | Multiple Myeloma

Promoting exercise for patients with multiple myeloma: attitudes and practices of clinical haematologists

Authors: Jennifer L. Nicol, Michelle M. Hill, Nicola W. Burton, Tina L. Skinner

Published in: Journal of Cancer Survivorship | Issue 3/2022

Login to get access

Abstract

Purpose

To explore the attitudes and practices of clinical haematologists towards promoting physical activity (PA) and exercise for patients with multiple myeloma (MM).

Methods

Using a quantitative cross-sectional survey, clinical haematologists reported on the perceived benefits and acceptability of PA and exercise and frequency, confidence and barriers to providing exercise advice.

Results

Clinical haematologists (n=34; 68% response rate), who cumulatively treated ~340 patients with MM each week, completed the survey. Almost all (97%) agreed that PA was important, with benefits for quality of life, activities of daily living, mental health and fatigue. Whilst 88% discussed PA at least occasionally with their patients, approximately two-thirds were not confident advising specific exercises (68%) or identifying PA resources (62%). Despite this, 44% never referred patients to exercise professionals, with 18% only doing so if the patient asked. Over half did not recommend exercise when patients had spine fractures or were physically unwell. No differences were observed in individual factors (age, gender, practice type and own PA participation) and promotion of PA.

Conclusions

Clinical haematologists perceive PA as important, but lack confidence on what exercise/s to recommend and if exercise is appropriate for specific disease complications. They tend to not refer patients to exercise professionals.

Implications for Cancer Survivors

Patients with MM often suffer from symptoms and toxicities that may be alleviated through PA. However, PA participation rates are low. Support for clinical haematologists for when and how to discuss exercise, and clearer referral pathways to exercise professionals may improve PA uptake and hence ensure access to optimal care, thereby improving patient outcomes.
Appendix
Available only for authorised users
Literature
12.
go back to reference Karvinen KH, DuBose KD, Carney B, Allison RR. Promotion of physical activity among oncologists in the United States. J Support Oncol. 2010;8(1):35–41.PubMed Karvinen KH, DuBose KD, Carney B, Allison RR. Promotion of physical activity among oncologists in the United States. J Support Oncol. 2010;8(1):35–41.PubMed
19.
go back to reference Haussmann A, Gabrian M, Ungar N, Jooss S, Wiskemann J, Sieverding M, et al. What hinders healthcare professionals in promoting physical activity towards cancer patients? The influencing role of healthcare professionals’ concerns, perceived patient characteristics and perceived structural factors. Eur J Cancer Care. 2018;27(4):e12853. https://doi.org/10.1111/ecc.12853.CrossRef Haussmann A, Gabrian M, Ungar N, Jooss S, Wiskemann J, Sieverding M, et al. What hinders healthcare professionals in promoting physical activity towards cancer patients? The influencing role of healthcare professionals’ concerns, perceived patient characteristics and perceived structural factors. Eur J Cancer Care. 2018;27(4):e12853. https://​doi.​org/​10.​1111/​ecc.​12853.CrossRef
24.
go back to reference Cormie P, Atkinson M, Bucci L, Cust A, Eakin E, Hayes S, et al. Clinical Oncology Society of Australia position statement on exercise in cancer care. Med J Aust. 2018;209(4):184–7.CrossRefPubMed Cormie P, Atkinson M, Bucci L, Cust A, Eakin E, Hayes S, et al. Clinical Oncology Society of Australia position statement on exercise in cancer care. Med J Aust. 2018;209(4):184–7.CrossRefPubMed
Metadata
Title
Promoting exercise for patients with multiple myeloma: attitudes and practices of clinical haematologists
Authors
Jennifer L. Nicol
Michelle M. Hill
Nicola W. Burton
Tina L. Skinner
Publication date
11-06-2021
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 3/2022
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01062-2

Other articles of this Issue 3/2022

Journal of Cancer Survivorship 3/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine